“…Various studies have mapped eQTLs in contexts relevant to immunity, with the measurement, in particular, of expression levels in the presence of immune (e.g., TLR ligands, IFNb, IFNg) or infectious (e.g., influenza A virus, Mycobacterium tuberculosis, Listeria monocytogenes) stimuli (Alasoo et al, 2018;Barreiro et al, 2012;Ç alıs xkan et al, 2015;Kim-Hellmuth et al, 2017;Lee et al, 2014;Né delec et al, 2016;Piasecka et al, 2018;Quach et al, 2016;Schmiedel et al, 2018;Ye et al, 2018). These studies have identified regulatory variants related to immune activation that act in cis or in trans (e.g., master regulators detected at IFNB1, IRF2, TLR1, or CR1), which are generally cell context dependent, and have revealed major overlaps between such variants and GWAS hits (see, for example, Kim-Hellmuth et al, 2017;Lee et al, 2014;Pala et al, 2017;Piasecka et al, 2018). These findings suggest that regulatory variation may underlie genetic associations with complex organismal phenotypes, such as infectious or autoimmune diseases (Wang et al, 2018).…”